Strategy
Challenges and Solutions in HCP ELISA Development
The importance of reliable Host Cell Protein (HCP) monitoring during manufacturing of biopharmaceutical drugs
Biopharmaceutical drugs make up a large portion of global pharma sales with of the top global drug blockbusters in being recombinant biopharmaceuticals Drug development is separable into five phases
SUEZ
Solving the toughest water and process challenges
Im originally from Belgium and I studied to be a chemical engineer with a specialisation in biochemistry and biotechnology When I started out it was my goal to get into the biochemistry or biotechnology industry as a plant director but when I graduated from university my first job was teaching chemistry biology and math Teaching was a very good exp...
Vietnam
EU Pharma's strategic imperative
Vietnam is the European Unions EU second largest trading partner in ASEAN and close to per cent of EU exports to Vietnam are pharma products For various midtosmall sized EU pharma players Vietnam has remained an alliance or a distributor led market With increase in demand positive economic prospects increase in per capita healthcare spending and t...
Health Canada New Validation Rules (Version 5.0)
For eCTD and non-eCTD Submissions
Health Canada is the Agency responsible for the wellbeing of the Canadians by ensuring highquality health services and minimising the health risks Regulatory submissions for Health Canada can be done in both electronic Common Technical Document eCTD and nonelectronic Common Technical Document noneCTD formats
The Swiss Chees Strategy
By copying the aviation industry, you can make sure your marketing strategy will fly
As you look at your newlywritten marketing plan you might want to reflect for a moment how much it resembles an airliner it took a lot of effort to build you want to be as sure as you can be that it will fly and not crash but once it takes off it is difficult to repair The biggest difference between a marketing strategy and an airliner is that whil...
Pharma Trade Terms in Asia-Pacific
Time for a reset!
Trade terms represent a growing investment and cost item for most Pharma companies globally In AsiaPacific APAC price pressures from limited healthcare budgets and preference to generics under universal coverage have led to additional challenges widening gross to net investments made by Pharma In our surveys from last year per cent of Pharma execu...
WORKING TOGETHER, APART
Strategic planning processes must adapt to the new normal of social distancing
Right now all over the world crossfunctional teams in pharma biotech medtech and other life science companies are working on their strategic plans Large or small companies usually follow this annual ritual
A Decade of Reinforcing Business Integrity
Making Asia-Pacific better prepared for COVID-19
The AsiaPacific APAC region is no stranger to confronting and defeating disease outbreaks From SARS and Avian influenza to MERS and HN the regions economies have demonstrated remarkable resilience and with each new occurrence found themselves better prepared to confront the challenge
VIRUS OUTBREAK
IMPACT ON PHARMA INDUSTRY
Viral outbreaks are not new to the world Before COVID we had other outbreaks such as Ebola in Swine Flu HN in and Severe Acute Respiratory Syndrome SARS outbreak in But the COVID outbreak became a pandemic and broke the record of all viral outbreak in past years forcing the World Health Organization WHO to declare health emergency globally
Natural Intelligence
True AI is a distant promise for marketers
Despite the hype the routine use of AI in marketing in the life sciences is a long way away
